OBM Geriatrics

(ISSN 2638-1311)

OBM Geriatrics is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.

Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.

Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.

Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

 
 
Publication Speed (median values for papers published in 2025): Submission to First Decision: 11.7 weeks; Submission to Acceptance: 21.5 weeks; Acceptance to Publication: 8.3 days (1-2 days of FREE language polishing included)
Open Access Correction
The Original Article was published on 03 April 2025

Correction: Baumann et al. Moldavian Dragonhead Extract: A Natural Collagen-Booster to Target Skin Aging. OBM Geriatrics 2025; 9: 305

Julia Baumann * ORCID logo, Eva Bönzli , Franziska Wandrey  ORCID logo, Torsten Grothe  ORCID logo

  1. Mibelle Group Biochemistry, 5033 Buchs, Aargau, Switzerland

Correspondence: Julia Baumann ORCID logo

Academic Editor: Taihao Quan

Special Issue: Aging of the Human Skin and Its Prevention

Received: June 07, 2026 | Accepted: June 07, 2026 | Published: June 09, 2026

OBM Geriatrics 2026, Volume 10, Issue 2, doi:10.21926/obm.geriatr.2602338

Recommended citation: Baumann J, Bönzli E, Wandrey F, Grothe T. Correction: Baumann et al. Moldavian Dragonhead Extract: A Natural Collagen-Booster to Target Skin Aging. OBM Geriatrics 2025; 9: 305. OBM Geriatrics 2026; 10(2): 338; doi:10.21926/obm.geriatr.2602338.

© 2026 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

The authors wish to make the following correction to the paper [1].

Replace:

2.1 Moldavian Dragonhead Extract Preparation

The Moldavian dragonhead extract (hereafter referred to as MDH Nu sd) was prepared as previously described [27], with some modifications. In short, the dry aerial parts of Dracocephalum moldavica L. were extracted with de-ionized water for 1 hour at 85-90°C by percolation. After vacuum concentration, the liquid extract was then spray-dried on 50% maltodextrin as a carrier (DracoBelle™ Nu sd, provided by Mibelle Group Biochemistry, Buchs, Switzerland). This process ensures a content of at least 2.5% of total flavonoid-glucuronides in the extract powder. The detailed nutritional values are found in Table S1.

With:

2.1 Moldavian Dragonhead Extract Preparation

The Moldavian dragonhead extract (hereafter referred to as MDH Nu sd) was prepared as previously described [27], with some modifications. In short, the dry aerial parts of Dracocephalum moldavica L. were extracted with de-ionized water for 1 hour at 85-90°C by percolation. After vacuum concentration, the liquid extract was then spray-dried on 50% maltodextrin as a carrier (DracoBelle™ Nu sd, provided by Mibelle Group Biochemistry, Buchs, Switzerland). This process ensures a content of at least 2.5 mg/g of total flavonoid-glucuronides in the extract powder. The detailed nutritional values are found in Table S1.

Competing Interests

The authors have declared that no competing interests exist.

Reference

  1. Baumann J, Bönzli E, Wandrey F, Grothe T. Moldavian dragonhead extract: A natural collagen-booster to target skin aging. OBM Geriatr. 2025; 9: 305. [CrossRef] [Google scholar]
Newsletter
Download PDF Download Citation
0 0

TOP